Move CGM and Pump Requests Forward With the Right Evidence and Payer Path

For the Original Medicare DME path reviewed on this page, the current Glucose Monitors LCD L33822 and related policy article govern CGM coverage and supplies alongside general DME documentation. The LCD identifies initial CGM criteria that include documented diabetes, practitioner-supported training through the prescription, use consistent with FDA indications, insulin treatment or the specified documented problematic-hypoglycemia path, and a qualifying practitioner visit within six months before ordering. It also describes a practitioner visit every six months for continued coverage. Durable insulin pumps follow separate national and local coverage material, and an integrated CGM-pump configuration may require both CGM and pump criteria. These are date-specific Medicare rules, not universal clinical criteria or instructions for another payer.

• Verify the current LCD, policy article, external-infusion-pump material, standard documentation article, DME MAC jurisdiction, product classification, effective date, and item-specific billing guidance before acting.
• Establish whether the requested CGM meets the DME benefit pathway and whether the receiver, integrated pump, durable pump, disposable pump, supplies, and insulin belong to Part B or a drug-plan path; do not infer the route from a brand or prior case.
• For delivered refills, the current standard DME documentation article requires an individualized request that affirms need before shipment and records the requested item and request date. A standing calendar or automatic shipment is not a substitute.
• A Standard Written Order, coverage evidence, correct coding, product classification, refill record, proof of delivery, assignment, and claim payment are distinct controls. Passing one does not prove the others.

Human handoff: The treating practitioner controls the prescription and clinical record. Qualified DME, pharmacy, coding, billing, and compliance staff apply the current Medicare sources and decide submission, delivery, modifiers, notices, and claims. Uncertain coverage questions go to the responsible DME MAC or qualified counsel, not the model.

Sources for this path: Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services

Medicare Advantage is not handled by copying an Original Medicare portal or resupply workflow. CMS rules require MA organizations to follow applicable Medicare coverage requirements for basic benefits, while the member’s plan terms, network, utilization-management process, contracted supplier or pharmacy, authorization instructions, and benefit presentation still shape operations. CMS’s diabetes-supplies fact sheet directs providers to check the MA plan for eligibility, coverage, payment, and plan-specific rules. The route must also distinguish a Part B device path from any connected drug-plan or pharmacy process.

• Confirm the exact MA plan, associated drug coverage, benefit channel, network supplier or pharmacy, authorization method, internal criteria when permitted, and current plan documents.
• Keep an Original Medicare LCD crosswalk visible where applicable, but do not treat a DME MAC transaction, fee-for-service claim response, or Original Medicare notice as the MA plan’s operational instruction.
• CMS-0057-F creates process and API obligations for impacted payers on specified schedules, but it does not prove that a particular plan, device, drug, portal, endpoint, or vendor connection is available to this organization.
• A plan transition, active course of treatment, supplier change, or benefit-channel change requires authorized review rather than automatic reuse of the prior approval or refill state.

Human handoff: Authorized MA and drug-plan specialists verify the current evidence and submission channel. Clinicians handle medical review, and contracting, supplier, pharmacy, compliance, or legal personnel resolve network, benefit, notice, continuity, and appeal questions.

Sources for this path: Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services

Medicaid CGM and pump coverage, reimbursement, pharmacy-versus-DME routing, quantity, prior authorization, preferred products, age or program conditions, supplier participation, and resupply rules can differ by state and by fee-for-service or managed-care delivery system. CMS-approved state plan amendments illustrate that states can change CGM benefit and reimbursement treatment. CMS-0057-F includes state Medicaid fee-for-service programs and Medicaid managed care among impacted payers for specified prior-authorization and interoperability provisions, but it does not create one national CGM qualification checklist.

• Identify the state program, eligibility category when operationally relevant, managed-care plan, benefit channel, preferred product, prescriber and supplier rules, and current effective date.
• Review the state provider manual, pharmacy and DME bulletins, preferred-product or prior-authorization material, managed-care instructions, and applicable federal requirements instead of importing Medicare criteria.
• Treat fee-for-service and managed-care responses as separate sources; a state policy summary does not establish the contracted plan’s portal, network, or submission status.
• Escalate pediatric, EPSDT, waiver, disability, continuity, fair-hearing, and exception questions to staff qualified for that state and program rather than encoding a national shortcut.

Human handoff: State Medicaid and managed-care specialists confirm the controlling source and channel. Treating clinicians own clinical support, while authorized payer, pharmacy, DME, compliance, and legal staff manage exceptions, notices, appeals, and hearings.

Sources for this path: Centers for Medicare & Medicaid Services, Medicaid.gov

Commercial access begins with the actual plan document, benefit design, contract, network, pharmacy-benefit manager or medical-benefit administrator, device policy, authorization instructions, and applicable federal or state requirements. A CGM or pump can move through different channels even within one carrier family. CMS-0057-F applies to specified impacted payers, including Qualified Health Plan issuers on Federally Facilitated Exchanges for defined provisions; CMS guidance notes that commercial plans outside those categories, such as employer-based plans, are not automatically brought into the rule. No CMS API rule should be described as universal commercial connectivity.

• Verify the funded arrangement, plan product, governing documents, applicable regulator, benefit channel, network, formulary or product policy, vendor, and current authorization and appeal instructions.
• Separate device qualification, prior authorization, pharmacy processing, DME supplier intake, contract allowance, patient financial communication, and final claim payment.
• Confirm whether any electronic transaction, portal, clearinghouse, or FHIR workflow is supported and contractually available; do not advertise an integration because a standard or regulation exists.
• Route ERISA, state mandate, external review, continuity, surprise-billing, notice, and financial-liability questions to qualified plan, compliance, or legal personnel.

Human handoff: Benefits and contracting staff establish the plan route; authorized pharmacy, supplier, and revenue-cycle personnel manage submissions; clinicians handle medical review; compliance or counsel decides plan-document, regulator, notice, appeal, and liability questions.

Sources for this path: Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services

A work-related injury, accident, liability claim, settlement, or other coverage can change who should pay first for related items and services. CMS explains that Medicare may be secondary to workers’ compensation, no-fault, or liability insurance and may make a conditional payment in defined circumstances. That coordination rule does not prove that a CGM, pump, replacement, or supply request is related to an incident, covered by a carrier, or payable by Medicare. Causation, primary responsibility, conditional payment, recovery, and settlement interests are fact-specific legal and payer decisions.

• Identify potential primary coverage and the relationship, if any, between the requested device or supply and the reported incident without asking the model to determine causation.
• Keep liability-carrier authorization, group-health coverage, Medicare eligibility, pharmacy or DME routing, conditional-payment information, and recovery correspondence in separate evidence lanes.
• Do not use an ABN, plan notice, denial, or patient agreement to bypass Medicare Secondary Payer rules or transfer liability without the required qualified review.
• Protect legal privilege and route settlement, recovery, reporting, causation, and future-medical questions to the organization’s authorized specialists or counsel.

Human handoff: Benefits-coordination staff, carrier representatives, authorized Medicare personnel, compliance leaders, and counsel determine primary-payer, reporting, conditional-payment, recovery, and settlement actions. Clinicians separately control treatment and documentation.

Sources for this path: Centers for Medicare & Medicaid Services